WebHistorical Volatility 133.1% Market Cap 4.6M Shares Outstanding 2.3M EPS (TTM, GAAP) -14.18 P/E Ratio (TTM, GAAP) -- Annual Dividend/Yield No dividend Ex-dividend Date No dividend Dividend Pay Date No dividend Beta 1.0 % Held by Institutions 11.18 Short Interest (% of float 02/28/23) 6.35 1d 2d 5d 1mo 3mo 6mo 1yr 3yr DJIA S&P 500 NASDAQ SMA … WebApr 7, 2024 · NASDAQ:FLKS Flex Pharma - FLKS News Today Notice: This company has been marked as potentially delisted and may not be actively trading. Compare Today's Range $1.34 $1.52 50-Day Range $0.57 $14.51 52-Week Range $0.26 $1.49 Volume 31,694 shs Average Volume 2.03 million shs Market Capitalization $26.20 million P/E …
FLKS (FLKS) Stock Price, News & Historical Data - TheStreet
WebApr 13, 2024 · NEWTON, Mass., April 13, 2024--Diversified Healthcare Trust (Nasdaq: DHC) today announced a regular quarterly cash distribution on its common shares of $0.01 per common share ($0.04 per share per year). This distribution will be paid to DHC’s common shareholders of record as of the close of business on April 24, 2024 and … WebLatest stock price today and the US's most active stock market forums. FLEX PHARMA, INC. (FLKS) stock price, charts, trades & the US's most popular discussion forums. the packhorse inn derbyshire
Unsafe baby cribs, historical precedent called on in federal ... - Yahoo
WebOct 15, 2024 · Flex Pharma Inc (NASDAQ:FLKS), which has zero-debt on its balance sheet, can maximize capital returns by increasing debt due to its lower cost of capital. However, the trade-off is FLKS Read More... WebThe FLKS dividend history graphic shown above is presented after taking into consideration any known stock split occurrences, in order to present the most directly comparable FLKS historical dividend comparison possible. Historical dividends, when charted graphically, can reveal the long-term variability and/or growth within the FLKS dividend ... WebFLKS Flex Pharma, Inc. Flex Pharma’s Phase 2 Trial with FLX-787 in Charcot-Marie-Tooth Endorsed by the Inherited Neuropathies Consortium -- US Phase 2 Trial of FLX-787 in CMT Patients to Start This Summer -- Click to Tweet this News Flex Pharma, Inc. (NASDAQ:FLKS), a clinical-stage biotechnology... shutdown windows pc from mac